Literature DB >> 21902183

Modulating magnetic dynamics of three Dy2 complexes through keto-enol tautomerism of the o-vanillin picolinoylhydrazone ligand.

Yun-Nan Guo1, Xiao-Hua Chen, Shufang Xue, Jinkui Tang.   

Abstract

Complexation of dysprosium(III) with the heterodonor chelating ligand o-vanillin picolinoylhydrazone (H(2)ovph) in the presence of different bases affords three new dinuclear dysprosium(III) coordination compounds, namely, [Dy(2)(ovph)(2)(NO(3))(2)(H(2)O)(2)]·2H(2)O (1), [Dy(2)(Hovph)(ovph)(NO(3))(2)(H(2)O)(4)]·NO(3)·2CH(3)OH·3H(2)O (2), and Na[Dy(2)(Hovph)(2)(μ(2)-OH)(OH)(H(2)O)(5)]·3Cl·3H(2)O (3), where the aroylhydrazone ligand adopts different coordination modes in respective structures depending on the reaction conditions, as revealed by single-crystal X-ray analyses to be due to their tautomeric maneuver. The magnetic properties of 1-3 are drastically distinct. Compounds 1 and 2 show single-molecule-magnet behavior, while no out-of-phase alternating-current signal is noticed for 3. The structural differences induced by the different coordinate fashions of the ligand may influence the strength of the local crystal field, the magnetic interactions between metal centers, and the local tensor of anisotropy on each Dy site and their relative orientations, therefore generating dissimilar dynamic magnetic behavior.

Entities:  

Year:  2011        PMID: 21902183     DOI: 10.1021/ic2014978

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  2 in total

1.  Bis[μ-N-(2-oxidobenzyl-idene)pyridine-2-carbohydrazidato]bis-[chlorido(methanol-κO)erbium(III)].

Authors:  Hua Yang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-04-13

2.  Experimental and theoretical interpretation of the magnetic behavior of two Dy(iii) single-ion magnets constructed through β-diketonate ligands with different substituent groups (-Cl/-OCH3).

Authors:  Sheng Zhang; Wenjiao Mo; Jiangwei Zhang; Haipeng Wu; Min Li; Xingqiang Lü; Bing Yin; Desuo Yang
Journal:  RSC Adv       Date:  2018-08-20       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.